NCT03817372

Brief Summary

Atrial fibrillation is the most common heart rhythm disorder, and the incidence is rapidly increasing. Cardioversion using an electrical shock (DC-cardioversion) is an important treatment to reduce symptoms and improve patient's quality-of-life. The treatment is performed by applying gel electrodes to the chest. Cardioversion is not always successful, and it is unknown which electrode-position provides the optimal efficacy. This study aims to compare two electrode positions, which are in clinical use: Anterior-posterior (left front and left back) versus anterior-lateral (right front and left side of the chest).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
468

participants targeted

Target at P75+ for not_applicable atrial-fibrillation

Timeline
Completed

Started Feb 2019

Shorter than P25 for not_applicable atrial-fibrillation

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

February 19, 2019

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2020

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

1.6 years

First QC Date

January 21, 2019

Last Update Submit

October 6, 2020

Conditions

Keywords

CardioversionElectrode position

Outcome Measures

Primary Outcomes (1)

  • Efficacy: First shock success

    The primary endpoint will be first shock efficacy, i.e. the proportion of patients in sinus rhythm for at least one minute immediately after an initial shock of 100 J.

    Immediately after first cardioversion attempt.

Secondary Outcomes (3)

  • Efficacy: Successful cardioversion

    One minute after cardioversion

  • Safety: Number of participants with arrhythmic events during and after cardioversion

    Within 2 hours after cardioversion (until discharge)

  • Safety: Number of participants with skin-discomfort, skin burns or itching

    Two hours after cardioversion (at discharge)

Study Arms (2)

Anterior-posterior electrode position

ACTIVE COMPARATOR

The anterior electrode is placed in the left parasternal area (precordium). The posterior electrode is placed in the left lower-scapular region with the electrode edge left to the spinal column.

Device: Anterior-posterior electrode position

Anterior-lateral electrode position

ACTIVE COMPARATOR

The anterior electrode is placed in the right parasternal area below the clavicle. The lateral electrode is placed with the center of the electrode in the left mid-axillary line in level with the V6 electrocardiogram electrode.

Device: Anterior-lateral electrode position

Interventions

Escalating energy shocks (100 J, 150 J, 200 J, 360 J) using anterior-posterior electrode position

Also known as: LIFEPAK 20, Physio-Control/Stryker
Anterior-posterior electrode position

Escalating energy shocks (100 J, 150 J, 200 J, 360 J) using anterior-lateral electrode position

Also known as: LIFEPAK 20, Physio-Control/Stryker
Anterior-lateral electrode position

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Atrial fibrillation (documented on an ECG-12)
  • Able and willing to sign informed consent
  • Age ≥ 18 years
  • Anticoagulation according to guidelines (Patients with atrial fibrillation for \>48 hours will be required to have a documented weekly international normalized ratio (INR) ≥2.0 (including within 48 hours of cardioversion) or treatment with non-vitamin K oral anticoagulant for three weeks or longer. Alternatively, a transoesophageal echocardiogram documenting the absence of intracardiac thrombi is accepted and cardioversion can be performed on treatment with low molecular weight heparin).

You may not qualify if:

  • Implanted pacemaker and/or cardioverter defibrillator (ICD)
  • Prior enrollment in the trial
  • Hemodynamically unstable atrial fibrillation
  • Untreated hyperthyroidism
  • Known or suspected pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Horsens Regional Hospital

Horsens, 8700, Denmark

Location

Randers Regional Hospital

Randers, 8930, Denmark

Location

Viborg Regional Hospital

Viborg, 8800, Denmark

Location

Related Publications (1)

  • Schmidt AS, Lauridsen KG, Moller DS, Christensen PD, Dodt KK, Rickers H, Lofgren B, Albertsen AE. Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation. Circulation. 2021 Dec 21;144(25):1995-2003. doi: 10.1161/CIRCULATIONAHA.121.056301. Epub 2021 Nov 24.

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Anders S Schmidt, MD

    Randers Regional Hospital

    PRINCIPAL INVESTIGATOR
  • Consultant cardiologist Andi E Albertsen, MD, PhD

    Viborg Regional Hospital

    STUDY DIRECTOR
  • Professor Bo Løfgren, MD, PhD, FESC, FAHA

    University of Aarhus

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2019

First Posted

January 25, 2019

Study Start

February 19, 2019

Primary Completion

October 2, 2020

Study Completion

October 2, 2020

Last Updated

October 8, 2020

Record last verified: 2020-10

Locations